Laboratory Reference Grade Compounds

PNC-27 (30mg Research Vial)

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱4,120.00
Out of stock
Net Content30MG
InclusionAnalytical Lab Set
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (30MG)
Diluent:mL
Concentration30.00 mg/mLin 1.0mL BAC
Standard Dose5 mg – 10 mg Daily SubQ / Analytical InfusionSyringe: 100.0 units (1.00 mL)
Scale (1 Unit)300 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
PNC-27 (30mg Research Vial)30MG · Analytical Lab Set
₱4,120.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: PNC-27 is an engineered anti-neoplastic research peptide consisting of the p53 amino acid sequence 12–26 (the HDM-2 binding domain) attached at its C-terminus to a transmembrane-penetrating leader sequence.

How it works: PNC-27 selectively targets and binds HDM-2 proteins situated within the plasma membranes of transformed cancerous cells, forming trans-membrane oligomeric pores that trigger rapid, non-apoptotic membrane lysis (oncolysis).

Why researchers study it: Researched in oncology models for targeted cytotoxicity against solid tumors and leukemias while demonstrating zero membrane-disruptive effects on healthy non-transformed cells.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryCognitive & Neuroprotective
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number879488-82-9
PubChem CID16132451↗
Molecular Weight4031.7 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options30MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaC188H293N53O44S